Clinical Trial Results: Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the impact of cladribine tablets on central nervous system biomarkers in multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Multiple Sclerosis Relapsing-remitting

Drugs mentioned

• Cladribine tablets (cladribine)

Snippet

Sponsor: Gregory Wu | Conditions: Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting | Phase 4 | Status: COMPLETED | Results posted: 2026-07-28